GET DAILY SIGNALSAehr Test Systems (AEHR) Stock Drops -44.9% in Past Month After Sharp Rally
Key Takeaways
- Aehr Test Systems shares fell roughly 44.9% over the past 30 days, declining from a closing price of $99.62 on September 30 to $54.89 on October 30.
- The pullback followed a sharp run-up that had lifted the stock from about $76.87 in late July to an intraday 52-week high of $147.40 in mid-August before the reversal.
- Over the last quarter, the stock is down approximately 28.6%, reflecting profit-taking, elevated valuation concerns, and reported insider selling after a strong fiscal 2026 finish.
- The company enters the period with a record effective backlog of roughly $100 million and fiscal 2027 revenue guidance of $130 million to $150 million, implying 160% to 200% year-over-year growth.
- Investor attention now centers on Aehr's first-quarter fiscal 2027 results, scheduled for November 2, 2026, with consensus revenue expectations near $27.5 million.
- For additional detail on valuation and performance, explore Price Targets, Earnings, and Forecast pages.
- To see how automated strategies are trading this and other tickers, explore Trending AI Robots.
Aehr Test Systems (AEHR) Company Overview and Market Position
Aehr Test Systems, headquartered in Fremont, California, designs and manufactures test and burn-in equipment used to stress-test semiconductor devices before they ship. The company's products include the FOX-P family of wafer-level test and burn-in systems, FOX WaferPak contactors, FOX DiePak carriers, and the high-power Sonoma family of package-level test and burn-in solutions for AI accelerators, GPUs, and high-performance computing processors.
Aehr operates in a specialized segment of the semiconductor capital equipment market, serving applications in artificial intelligence, silicon photonics, data centers, automotive and electric vehicles, and industrial power semiconductors. I follow the stock closely because the company has positioned its burn-in technology around the growing reliability requirements of AI processors, where a single defective device can be costly at data-center scale. Its competitive set includes established test and burn-in equipment providers such as Teradyne (TER), which has also signaled entry into AI-focused burn-in markets. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Aehr Test Systems (AEHR) Stock Price Performance: Last 30 Days vs. Quarter
Over the last 30 days, AEHR declined from $99.62 at the close on September 30 to $54.89 at the close on October 30, a drop of approximately 44.9%. The move was not a single-day event but a steady grind lower punctuated by sharp sessions, including an 11.7% single-day decline on October 6.
The last quarter tells a broader, more volatile story. The stock closed near $76.87 on July 30, surged to a closing high of $145.61 on August 17 after strong earnings and guidance, and then gave back those gains through September and October. Measured from the end of July, the stock is down roughly 28.6% over the quarter, even as it remains well above its 52-week low of $18.70. The overall trend has been characterized by rapid appreciation followed by a pronounced correction toward the end of the period.
What Drove AEHR Stock Price in the Last 30 Days
The 30-day decline followed a period of exceptional momentum. After rallying sharply on fiscal fourth-quarter results and an aggressive fiscal 2027 outlook, the stock entered October near $107 before a decisive reversal. Market commentary during the period pointed to several contributing factors rather than a single catalyst.
Valuation emerged as a recurring theme. Aehr's price-to-sales ratio of roughly 34 was substantially above its historical median near 4.8, and some independent valuation models placed the stock's estimated intrinsic value well below its traded price. Reports also highlighted sustained insider selling of approximately $62.5 million over the trailing 12 months with no insider purchases, which weighed on sentiment.
Company-specific news remained broadly positive. On October 7, Aehr announced approximately $6 million in follow-on Sonoma production orders from its lead hyperscale customer for a next-generation AI processor, and on October 29 it appointed former Meta infrastructure executive Vijay Rao to its board. Positioning ahead of the November 2 earnings report, however, appears to have kept sellers in control as investors reduced risk into the print.
What Drove AEHR Stock Performance Over the Last Quarter
The quarter's defining event was Aehr's fiscal 2026 fourth-quarter report on July 14. The company posted revenue of $18.8 million, up 34% year over year, and non-GAAP earnings of $0.11 per share versus expectations for a loss. Record quarterly bookings of $60.7 million lifted backlog to $80.6 million, with an effective backlog of roughly $100 million including post-quarter orders.
Management guided fiscal 2027 revenue to between $130 million and $150 million, representing 160% to 200% year-over-year growth. Analysts responded favorably, with Lake Street raising its price target to $110 from $56 while reiterating a Buy rating. The stock's mid-August peak reflected enthusiasm around AI-driven burn-in demand and a record backlog, before elevated valuations and profit-taking triggered a multi-week correction that extended into late October.
AEHR Stock Forecast Drivers: What Investors Should Watch Next
Aehr's first-quarter fiscal 2027 report on November 2 is the near-term focal point, with consensus estimates near $27.5 million in revenue and a projected year-over-year surge in earnings per share. Investors will watch whether the company's record backlog converts into shipped revenue on schedule and whether guidance for fiscal 2027 is reaffirmed or adjusted.
Beyond earnings, key factors include demand trends for AI accelerators and silicon photonics, execution on large hyperscale orders, competitive pressure from larger test-equipment vendors, and the pace of any new customer wins. Macroeconomic conditions affecting semiconductor capital spending and data-center investment will also influence sentiment, as will valuation multiples that remain elevated relative to historical norms. These factors do not constitute investment advice but frame the variables most likely to shape the stock's trajectory in the months ahead. From what I see, monitoring these elements closely will be important in the coming weeks.
Exploring Tickeron’s AI Tools in My Research
In my own analysis workflow, I frequently rely on Tickeron’s AI Trend Prediction Engine to cross-reference potential price movements and identify supporting patterns across similar names. It provides an additional layer of data-driven insight that helps me evaluate how broader market signals align with company-specific developments. This approach keeps my reviews grounded without replacing traditional fundamental work.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.
AEHR sees MACD Histogram crosses below signal line
AEHR saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on October 07, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 37 instances where the indicator turned negative. In 34 of the 37 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 06, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AEHR as a result. In 75 of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 88%.
AEHR moved below its 50-day moving average on October 06, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for AEHR crossed bearishly below the 50-day moving average on October 09, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 14 of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 82%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AEHR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.
The Aroon Indicator for AEHR entered a downward trend on October 30, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where AEHR's RSI Oscillator exited the oversold zone, 27 of 32 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 84%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 51 of 56 cases where AEHR's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 90%.
Following a +14.03% 3-day Advance, the price is estimated to grow further. Considering data from situations where AEHR advanced for three days, in 245 of 274 cases, the price rose further within the following month. The odds of a continued upward trend are 89%.
AEHR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 5 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.167) is normal, around the industry mean (6.482). P/E Ratio (-238.652) is within average values for comparable stocks, (90.479). Projected Growth (PEG Ratio) (0.927) is also within normal values, averaging (0.801). Dividend Yield (0.000) settles around the average of (0.008) among similar stocks. P/S Ratio (51.813) is also within normal values, averaging (27.897).
The Tickeron PE Growth Rating for this company is 18 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 63 (best 1 - 100 worst), indicating fairly steady price growth. AEHR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 69 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AEHR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 73, placing this stock better than average.
The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a manufacturer of burn-in and test equipment for semiconductor manufacturing
Industry ElectronicProductionEquipment
Advertisement